TCM
BIB icon

Traynor Capital Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Traynor Capital Management’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,813
Closed -$298K – 181
2022
Q1 		$298K Sell
4,813
-1,064
-18% -$65.3K 0.04% 136
2021
Q4 		$476K Buy
5,877
+858
+17% +$73.5K 0.06% 129
2021
Q3 		$476K Buy
5,019
+690
+16% +$69.8K 0.07% 121
2021
Q2 		$432K Buy
4,329
+212
+5% +$18.5K 0.06% 122
2021
Q1 		$344K Buy
4,117
+570
+16% +$53.8K 0.06% 121
2020
Q4 		$306K Sell
3,547
-630
-15% -$48.8K 0.05% 118
2020
Q3 		$295K Buy
4,177
+123
+3% +$8.72K 0.07% 112
2020
Q2 		$294K Buy
+4,054
New +$259K 0.07% 116
2018
Q4 		– Sell
-3,969
Closed -$276K – 162
2018
Q3 		$276K Sell
3,969
-27
-0.7% -$1.76K 0.09% 140
2018
Q2 		$232K Sell
3,996
-280
-7% -$15.3K 0.08% 152
2018
Q1 		$235K Buy
4,276
+67
+2% +$4.01K 0.1% 146
2017
Q4 		$235K Buy
4,209
+497
+13% +$28K 0.1% 144
2017
Q3 		$223K Buy
+3,712
New +$211K 0.11% 137
2016
Q4 		– Sell
-6,511
Closed -$268K – 132
2016
Q3 		$268K Sell
6,511
-1,579
-20% -$75K 0.19% 99
2016
Q2 		$320K Sell
8,090
-3,005
-27% -$130K 0.25% 88
2016
Q1 		$453K Buy
11,095
+5,426
+96% +$240K 0.36% 60
2015
Q4 		$405K Sell
5,669
-2,566
-31% -$171K 0.29% 75
2015
Q3 		$479K Buy
8,235
+1,550
+23% +$132K 0.41% 53
2015
Q2 		$604K Buy
6,685
+645
+11% +$55.5K 0.5% 43
2015
Q1 		$478K Buy
6,040
+2,170
+56% +$161K 0.46% 47
2014
Q4 		$242K Buy
+3,870
New +$227K 0.28% 85

Other funds holding BIB

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Traynor Capital Management's BIB Position: Q2 2022 in Review

Traynor Capital Management sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2022, closing a stake of 4,813 shares — an estimated $298K sold.

Traynor Capital Management first reported a position in BIB in Q4 2014 and held it in 21 quarters. The position peaked at $604K in Q2 2015. 24 funds tracked by Wall St. Rank hold BIB as of Q2 2022.

  • Traynor Capital Management reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q2 2022 after selling out during the quarter.
  • Traynor Capital Management sold 4,813 ProShares Ultra NASDAQ Biotechnology shares in Q2 2022, an estimated $298K.
  • Traynor Capital Management first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2014 and held it in 21 quarters.
  • Traynor Capital Management's ProShares Ultra NASDAQ Biotechnology position peaked at $604K in Q2 2015.
  • 24 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2022.

Based on Traynor Capital Management's 13F filing for Q2 2022, filed 28 Jul 2022.